 |
Corporate News
07-Sep-20
|
|
|
|
|
|
|
|
|
|
|
|
Alembic Pharmaceuticals receives USFDA approval for Treprostinil Injection
|
|
|
|
|
|
|
|
Alembic Pharmaceuticals has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Treprostinil Injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml
(1 O mg/ml), Multiple-Dose Vials. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RlD), Remodulin Injection, 20 mg/20 ml (1 mg/ml), 50 mg/20 ml (2.5 mg/ml), 100 mg/20 ml (5 mg/ml), and 200 mg/20 ml (10mg/ml), of United Therapeutics Corp. (United). Treprostinil Injection is indicated for the
treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise.
Treprostinil Injection has an estimated market size of US$ 466.1 million for twelve months
ending Dec. 2019 according to United Therapeutics Corporation's 2019 financial results.
Alembic now has a total of 131 ANDA approvals (113 final approvals and 18 tentative
approvals) from USFDA.
|
|
|
|
Previous News |
Alembic Pharmaceuticals' derma unit at Karakhadi clears USFDA inspection
(
Corporate News
-
13-Mar-23
09:08
)
|
|
|
Alembic Pharma gets USFDA nod for Doxycycline Capsules
(
Hot Pursuit
-
28-Jun-24
12:20
)
|
|
|
Alembic Pharmaceuticals receives USFDA approval for Docetaxel Injection
(
Corporate News
-
01-Mar-23
15:51
)
|
|
|
Alembic Pharma gets USFDA nod for hypertension drug
(
Hot Pursuit
-
30-Mar-23
14:08
)
|
|
|
Alembic Pharmaceuticals to declare Quarterly Result
(
Corporate News
-
18-Apr-24
16:14
)
|
|
|
Alembic Pharma says USFDA clears Karakhadi facility
(
Hot Pursuit
-
13-Mar-23
09:35
)
|
|
|
Alembic Pharma jumps on USFDA nod for glaucoma drug
(
Hot Pursuit
-
31-Mar-23
10:10
)
|
|
|
Board of Alembic Pharmaceuticals recommends Interim dividend
(
Corporate News
-
05-Aug-22
10:48
)
|
|
|
Alembic Pharma Q2 PAT falls 19% YoY; R&D spend at Rs 168 crore
(
Hot Pursuit
-
11-Nov-22
14:21
)
|
|
|
USFDA inspects Alembic Pharma's solid oral formulation facility at Jarod
(
Corporate News
-
19-Dec-22
12:51
)
|
|
|
Alembic Pharma Bioequivalence facility completes USFDA inspection with no observations
(
Hot Pursuit
-
25-Oct-22
11:01
)
|
|
|
|
|
|
Other Stories |
|
|
|
|
|
|
|
|
|
|
|
|
|